Do prostate cancer patients at risk of pelvic lymph-node metastasis benefit from pelvic radiation?

被引:0
作者
Palapattu, G. S. [1 ]
Messing, E. M. [1 ]
机构
[1] Univ Rochester, Dept Urol, James P Wilmot Canc Ctr, Sch Med, Rochester, NY 14627 USA
来源
NATURE CLINICAL PRACTICE UROLOGY | 2006年 / 3卷 / 05期
关键词
brachytherapy; pelvic radiation; prostate cancer; radiation therapy;
D O I
10.1038/ncpuro0463
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:258 / 259
页数:2
相关论文
共 50 条
  • [41] External validation of a nomogram for unilateral pelvic lymph node dissection in prostate cancer
    Ortner, Gernot
    Falkenbach, Fabian
    Kachanov, Mykyta
    Inderhees, Tim
    Maurer, Tobias
    Knipper, Sophie
    Graefen, Markus
    Budaeus, Lars
    BJU INTERNATIONAL, 2025,
  • [42] PREDICTING PELVIC LYMPH NODE INVOLVEMENT IN CURRENT-ERA PROSTATE CANCER
    Rahman, Sophia
    Cosmatos, Harry
    Dave, Giatri
    Williams, Stephen
    Tome, Michael
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 82 (02): : 906 - 910
  • [43] Endogenous testosterone density is an independent predictor of pelvic lymph node invasion in high-risk prostate cancer: results in 201 consecutive patients treated with radical prostatectomy and extended pelvic lymph node dissection
    Antonio Benito Porcaro
    Alessandro Tafuri
    Andrea Panunzio
    Giovanni Mazzucato
    Clara Cerrato
    Sebastian Gallina
    Alberto Bianchi
    Riccardo Rizzetto
    Nelia Amigoni
    Emanuele Serafin
    Francesco Cianflone
    Rossella Orlando
    Ilaria Gentile
    Filippo Migliorini
    Stefano Zecchini Antoniolli
    Giacomo Di Filippo
    Matteo Brunelli
    Vincenzo Pagliarulo
    Maria Angela Cerruto
    Alessandro Antonelli
    International Urology and Nephrology, 2022, 54 : 541 - 550
  • [44] Endogenous testosterone density is an independent predictor of pelvic lymph node invasion in high-risk prostate cancer: results in 201 consecutive patients treated with radical prostatectomy and extended pelvic lymph node dissection
    Porcaro, Antonio Benito
    Tafuri, Alessandro
    Panunzio, Andrea
    Mazzucato, Giovanni
    Cerrato, Clara
    Gallina, Sebastian
    Bianchi, Alberto
    Rizzetto, Riccardo
    Amigoni, Nelia
    Serafin, Emanuele
    Cianflone, Francesco
    Orlando, Rossella
    Gentile, Ilaria
    Migliorini, Filippo
    Antoniolli, Stefano Zecchini
    Di Filippo, Giacomo
    Brunelli, Matteo
    Pagliarulo, Vincenzo
    Cerruto, Maria Angela
    Antonelli, Alessandro
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2022, 54 (03) : 541 - 550
  • [45] Clinical outcomes of definitive whole pelvic radiotherapy for clinical lymph node metastatic prostate cancer
    Tsuchida, Keisuke
    Inaba, Koji
    Kashihara, Tairo
    Murakami, Naoya
    Okuma, Kae
    Takahashi, Kana
    Igaki, Hiroshi
    Nakayama, Yuko
    Maejima, Aiko
    Shinoda, Yasuo
    Matsui, Yoshiyuki
    Komiyama, Motokiyo
    Fujimoto, Hiroyuki
    Ito, Yoshinori
    Sumi, Minako
    Nakano, Takashi
    Itami, Jun
    CANCER MEDICINE, 2020, 9 (18): : 6629 - 6637
  • [46] Matched-pair analysis of prostate cancer patients with a high risk of positive pelvic lymph nodes treated with and without pelvic RT and high-dose radiation using high dose rate brachytherapy
    Vargas, Carlos E.
    Demanes, Jeffrey
    Boike, Thomas P.
    Barnaba, Marie-Claire
    Skoolisariyaporn, Pat
    Schour, Lionel
    Gustafson, Gary S.
    Gonzalez, Jose
    Martinez, Alvaro A.
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2006, 29 (05): : 451 - 457
  • [47] Role of prostate dose escalation in patients with greater than 15% risk of pelvic lymph node involvement
    Jacob, R
    Hanlon, AL
    Horwitz, EM
    Movsas, B
    Uzzo, RG
    Pollack, A
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2005, 61 (03): : 695 - 701
  • [48] Management of Patients with Node-positive Prostate Cancer at Radical Prostatectomy and Pelvic Lymph Node Dissection: A Systematic Review
    Marra, Giancarlo
    Valerio, Massimo
    Heidegger, Isabel
    Tsaur, Igor
    Mathieu, Romain
    Ceci, Francesco
    Ploussard, Guillaume
    van den Bergh, Roderick C. N.
    Kretschmer, Alexander
    Thibault, Constance
    Ost, Piet
    Tilki, Derya
    Kasivisvanathan, Veeru
    Moschini, Marco
    Sanchez-Salas, Rafael
    Gontero, Paolo
    Karnes, R. Jeffrey
    Montorsi, Francesco
    Gandaglia, Giorgio
    EUROPEAN UROLOGY ONCOLOGY, 2020, 3 (05): : 565 - 581
  • [49] Survival Outcomes of Radical Prostatectomy plus Extended Pelvic Lymph Node Dissection and Radiotherapy in Prostate Cancer Patients With a Risk of Lymph Node Invasion Over 5%: A Population-Based Analysis
    Chen, Junru
    Ni, Yuchao
    Sun, Guangxi
    Zhu, Sha
    Zhao, Jinge
    Wang, Zhipeng
    Zhang, Haoran
    Zhu, Xudong
    Zhang, Xingming
    Dai, Jindong
    Shen, Pengfei
    Zeng, Hao
    FRONTIERS IN ONCOLOGY, 2020, 10
  • [50] Benefit of a more extended pelvic lymph node dissection among patients undergoing radical prostatectomy for localized prostate cancer: A causal mediation analysis
    Wettstein, Marian S.
    David, Luke A.
    Pazhepurackel, Clinsy
    Qureshi, Aatif A.
    Zisman, Alex
    Nesbitt, Michael
    Saba, Karim
    Herrera-Caceres, Jaime O.
    Fankhauser, Christian D.
    Ahmad, Ardalan
    Hamilton, Robert J.
    Eberli, Daniel
    Zlotta, Alexandre R.
    Sulser, Tullio
    Fleshner, Neil E.
    Poyet, Cedric
    Finelli, Antonio
    Hermanns, Thomas
    Kulkarni, Girish S.
    PROSTATE, 2021, 81 (05) : 286 - 294